Smartlab Europe

Press Releases

Symbiosis invests $1.5 million in UK facility expansion

Stirling, UK – Fast-growing specialist sterile manufacturing and Contract Manufacturing Organisation (CMO) Symbiosis Pharmaceutical Services (Symbiosis), has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%. In the last 12 months Symbiosis has invested over £1.5m ($1.9m) in...

Aptar Pharma to Highlight Drug Delivery Solutions Portfolio and Expanded Services Offering at Pharmapack 2020

Aptar Pharma, a global leader in drug delivery systems and active packaging solutions, announces that it will be a leading exhibitor at Pharmapack 2020, which will take place February 5-6 at Paris Expo, Porte de Versailles, in Paris, France. Located...

FedEx Express Strengthens Clinical Trial Logistics Services for Global Pharmaceutical Customers

Following the completed renovation of the TNT Life Science Center in Tokyo, Japan in May 2019, FedEx Express is bolstering its healthcare solutions to support and better meet the complex logistics needs of its pharmaceutical customers in Asia Pacific....

Novartis and Forendo enter into tissue hormone focused licensing collaboration

Finland-based Forendo Pharma has announced it has signed a licensing and collaboration agreement with Novartis. The research collaboration will focus on discovering and developing HSD17B (17-beta-hydroxysteroid dehydregonase) inhibitors, which is a family of enzymes that regulates hormone action in specific...

MedPharm moves into $4M expansion of its North Carolina facility

MedPharm, the leader in topical and transdermal drug delivery, has moved into its newly expanded facility in Durham, North Carolina. The $4M expansion has tripled the facility’s footprint to approximately 25,000 sq. ft, significantly expanding capacity and supporting MedPharm’s continued...

Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced an expanded antibody optimization collaboration with Pandion Therapeutics. Based on the successful completion of its first project for...

PCI Pharma Services Announces Major Investment to Expand Development and Manufacturing Capabilities at Tredegar, UK Site

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced it has begun an expansion of its Tredegar facility in Wales, UK to enhance its high potent drug manufacturing and development capabilities, including both clinical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »